Sentien Co-Founder Dr. Biju Parekkadan to speak at ASGCT Meeting

Posted May 9, 2017

Dr. Parekkadan will discuss Ex Vivo Blood Conditioning Using Tissue Engineered Reactors at the ASGCT 2017 Annual Meeting in Washington, DC. His presentation will be on Saturday, May 13th at 10:45 am during the Somatic Stem Cell Therapies session.